Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182877 | 0.81 | MAPT (0.52) | MAPTALDH1A1TDP1L3MBTL1HTT | |
| SCHEMBL632545 | 0.81 | MAPT (0.54) | CA12CA2CA9MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL17710400 | 0.79 | MAPT (0.50) | MAPTALDH1A1TDP1L3MBTL1HTT | |
| Ammonia Solution, Strong SCHEMBL6702357 | 0.79 | MAPT (0.50) | MAPTALDH1A1TDP1L3MBTL1HTT | |
| Iodide SCHEMBL29028129 | 0.79 | MAPT (0.50) | MAPTALDH1A1TDP1L3MBTL1HTT | |
| SCHEMBL27787299 | 0.78 | MAPT (0.46) | CA12CA1CA2CA9MAPT | |
| SCHEMBL16197831 | 0.77 | MAPT (0.58) | MAPTALDH1A1TDP1HTTSMN1; SMN2 | |
| SCHEMBL1674517 | 0.77 | MAPT (0.58) | MAPTALDH1A1TDP1HTTSMN1; SMN2 | |
| SCHEMBL11048403 | 0.77 | MAPT (0.48) | MAPTALDH1A1TDP1L3MBTL1HTT | |
| SCHEMBL5257356 | 0.77 | MAPT (0.48) | MAPTALDH1A1TDP1L3MBTL1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125349-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | UNIV POITIERS (FR) | 2026-05-07 | — | — | US | disclosed |
| EP-4598903-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | Université de Poitiers (FR) | 2025-08-13 | — | — | EP | disclosed |
| CN-120035579-A | Process for fluorinating and/or cyclizing an amino alkene or alkyne in a continuous flow and apparatus for carrying out the process | 普瓦捷大学 | 2025-05-23 | — | — | CN | disclosed |
| WO-2024074501-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | UNIVERSITE DE POITIERS (FR) | 2024-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125349-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | FIBP, FGB, SUB1 | CA12 1001/4885CA1 382/4885CA2 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.